[Retracted] Efficacy and Safety of Bifidobacterium Quadruple Viable Bacteria Combined with Mesalamine against UC Management: A Systematic Review and Meta-Analysis

Table 1

List of basic features of literature.

	Age (years old)		Number of samples		Interventions		Duration of treatment (month)	Outcomes
	E	C	E	C	E	C
Zhang J [37]			38	38	M+QB	M	2	1; 2; 3; 4; 5
Zhang Y [37]			55	55	M+QB	M	2	2; 4; 5; 6; 7; 8; 9; 10
Che J [42]			37	37	M+QB	M	12	2; 4; 5; 6; 10
Cheng P [43]			30	30	M+QB	M	1	2; 4; 5; 10
Guo ET [44]			65	65	M+QB	M	1.5	4; 6; 8; 9; 10
Hou J [45]			43	43	M+QB	M	2	1; 2; 3; 4; 5; 6
Hou LL [25]			79	79	M+QB	M	2	2; 5; 6; 10
Jin Y [46]			52	52	M+QB	M	2	4; 6; 10
Pang YM [47]			51	51	M+QB	M	1.5	6; 8; 9
Ruan RH [48]			42	42	M+QB	M	1.5	2; 3; 4; 5; 6
Sun ZY [49]			44	44	M+QB	M	2	5; 6; 8; 9
Tan WK [50]			25	25	M+QB	M	3	2; 5; 6
Wang SJ [51]			26	26	M+QB	M	1	5; 10
Wang YG [52]			75	75	M+QB	QB	1.5	2; 3; 4; 5; 6
Wang YD [53]			41	42	M+QB	M	1.5	2; 3; 4; 5; 6
Wang YB [54]			46	46	M+QB	M	2	6; 7; 8
Xu JY [55]			36	36	M+QB	M	1.5	5; 6; 7; 8; 9
Yue YY [56]			32	32	M+QB	M	1	1; 5; 6
Zheng Y [57]			36	36	M+QB	M	2	1; 2; 6

Note: E: test group; RCT: randomized controlled trial; C: control group; M: mesalamine; QB: Bifidobacterium quadruple viable bacteria; 1: Mayo Score; 2: hs-CRP hypersensitive C-reactive protein; 3: IL-4: Interleukin-4; 4: IL-8: Interleukin-8; 5: adverse reactions; 6: total efficiency; 7: ox-LDL: oxidized low density lipoprotein; 8: LPO: lipid peroxide; 9: SOD: superoxide dismutase; 10: TNFα: tumor necrosis factor.